Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial

John A. Todd(University of Oxford), Frank Waldron-Lynch(University of Cambridge), Goymer Donna(University of Cambridge), Chris Wallace(University of Cambridge), Ian Goodfellow(University of Cambridge), Kevin W. Loudon(University of Cambridge), Laura Esposito(University of Cambridge), Adrian Mander(MRC Biostatistics Unit), Jane Kennet(Cambridge University Hospitals NHS Foundation Trust), Jane Greatorex(Cambridge University Hospitals NHS Foundation Trust), Sarah Caddy, Simon Bond(Cambridge University Hospitals NHS Foundation Trust), Antony J. Cutler(University of Cambridge), Marcin Ł. Pękalski(Centre for Human Genetics), Irons Kathryn(Cambridge University Hospitals NHS Foundation Trust), Challis Ben(National Institute for Health and Care Research), Mark L. Evans, Helen Schuilenburg(University of Cambridge), Linda S. Wicker(Juvenile Diabetes Research Foundation), Timothy Tree(King's College London), James Heywood(University of Cambridge), Jennie H. M. Yang(Mayo Clinic), Sankalpa Neupane(National Institute for Health and Care Research), Neil Walker, Jia Lu(University of Cambridge), Anselmiova Katerina(University of Cambridge), Ricardo C. Ferreira(Centre for Human Genetics), Clarke Pamela(University of Cambridge), Sarah Dawson(Papworth Hospital NHS Foundation Trust), Brown Judy(University of Cambridge), Linsey Porter(University of Cambridge), Daniel B. Rainbow(University of Cambridge), Helen Stevens(University of Cambridge), Gillian Coleman(University of Cambridge), Deborah J. Smyth(University of Cambridge), Kara Hunter(University of Cambridge), Marina Evangelou(University of Cambridge)
PLoS Medicine
October 11, 2016
Cited by 140


Related Papers